Guidance on CMC for Phase 1 and Phases 2/3 Investigational ...

Guidance on CMC for Phase 1 and Phases 2/3 Investigational New Drug Applications Charles P. Hoiberg, Ph.D. Executive Director, Pfizer Board Member, FDA Alumni Association

  Phases, Applications, Drug, Investigational, And phases 2 3 investigational new drug applications, And phases 2 3 investigational